Annual Drug Patent Expirations for KYNMOBI
Kynmobi is a drug marketed by Sumitomo Pharma Am and is included in one NDA. There are fifteen patents protecting this drug.
Drug patent litigation for KYNMOBI.
This drug has two hundred and forty patent family members in twenty-six countries.
The generic ingredient in KYNMOBI is apomorphine hydrochloride. Additional details are available on the apomorphine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
